Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Beneficial Ownership Report · SCHEDULE 13G/A

Freenome, Inc.

FRNMNASDAQEQUITYCurrent

Beneficial Ownership Report

Filed Nov 16, 2026Accepted Nov 16, 2026, 5:05 PM ESTFiling CIK 2017526Accession 0001193125-26-463807
Share

Structured filing — SCHEDULE 13G/A

primary_doc.xml

Open full document ↗

Amendment · This filing reports the amendment as submitted.

Subject company

Company
Freenome, Inc.
Company CIK
0002017526
Street
Genesis Marina, 3300 Marina Blvd
City
Brisbane
State / country code
CA
Postal code
94005

Statement details

Amendment number
1
Security class
Common Stock, par value $0.0001 per share
Event date
09/30/2026
Rule designation
Rule 13d-1(c)

Reporting person 1

Name
Perceptive Advisors LLC
Citizenship / organization
DE
Reporting person type
IA
Group designation
b
Aggregate amount owned
12,606,053
Percent of class
11.3
Sole voting power
0
Shared voting power
12,606,053
Sole dispositive power
0
Shared dispositive power
12,606,053
Aggregate excludes certain shares
N

Reporting person 2

Name
Joseph Edelman
Citizenship / organization
X1
Reporting person type
IN
Group designation
b
Aggregate amount owned
12,606,053
Percent of class
11.3
Sole voting power
0
Shared voting power
12,606,053
Sole dispositive power
0
Shared dispositive power
12,606,053
Aggregate excludes certain shares
N

Reporting person 3

Name
Perceptive Life Sciences Master Fund, Ltd.
Citizenship / organization
E9
Reporting person type
CO
Group designation
b
Aggregate amount owned
12,518,597
Percent of class
11.2
Sole voting power
0
Shared voting power
12,518,597
Sole dispositive power
0
Shared dispositive power
12,518,597
Aggregate excludes certain shares
N

Reporting person 4

Name
C2 Life Sciences LLC
Citizenship / organization
NY
Reporting person type
OO
Group designation
b
Aggregate amount owned
87,456
Percent of class
0.1
Sole voting power
0
Shared voting power
87,456
Sole dispositive power
0
Shared dispositive power
87,456
Aggregate excludes certain shares
N

Item 1

Issuer

Freenome, Inc.

Principal executive office address

Genesis Marina, 3300 Marina Blvd, Brisbane, California, 94005

Item 2

Citizenship

Perceptive Advisors is a Delaware limited liability company. Mr. Edelman is a United States citizen. The Master Fund is a Cayman Islands corporation. C2 is a New York limited liability company.

Filing person

The names of the persons filing this report (collectively, the "Reporting Persons") with respect to the Common Stock, par value $0.0001 per share (the "Common Stock") of Freenome, Inc. (the "Issuer") are: (i) Perceptive Advisors LLC ("Perceptive Advisors") (ii) Joseph Edelman ("Mr. Edelman") (iii) Perceptive Life Sciences Master Fund, Ltd. (the "Master Fund") (iv) C2 Life Sciences LLC ("C2")

Principal business or residence address

The address of the principal business office of each of the Reporting Persons is: 51 Astor Place, 10th Floor, New York, NY 10003

Item 3

Not applicable indication

Y

Item 4

Percent of class

Perceptive Advisors: 11.3% Mr. Edelman: 11.3% Master Fund: 11.2% C2: 0.1%

Amount beneficially owned

The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover pages to this Schedule 13G. The ownership percentages reported are based on 111,500,956 shares of Common Stock outstanding as of November 9, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2026. Neither Perceptive Advisors nor Mr. Edelman directly holds any Common Stock. The Master Fund directly holds 12,518,597 shares of Common Stock, and C2 directly holds 87,456 shares of Common Stock. Perceptive Advisors serves as the investment manager to the Master Fund and C2, and may be deemed to beneficially own shares held by the Master Fund and C2. Mr. Edelman is the managing member of Perceptive Advisors and may be deemed to beneficially own the shares held by the Master Fund and C2.

Sole voting power

Perceptive Advisors: 0 Mr. Edelman: 0 Master Fund: 0 C2: 0

Shared voting power

Perceptive Advisors: 12,606,053 Mr. Edelman: 12,606,053 Master Fund: 12,518,597 C2: 87,456

Sole dispositive power

Perceptive Advisors: 0 Mr. Edelman: 0 Master Fund: 0 C2: 0

Shared dispositive power

Perceptive Advisors: 12,606,053 Mr. Edelman: 12,606,053 Master Fund: 12,518,597 C2: 87,456

Item 5

Not applicable indication

Y

Item 6

Not applicable indication

Y

Item 7

Not applicable indication

Y

Item 8

Not applicable indication

Y

Item 9

Not applicable indication

Y

Item 10

Not applicable indication

N

Certifications

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

Signature 1

Reporting person
Perceptive Advisors LLC
Signed
/s/ Joseph Edelman
Title
Joseph Edelman, Managing Member
Date
11/16/2026

Signature 2

Reporting person
Joseph Edelman
Signed
/s/ Joseph Edelman
Title
Joseph Edelman
Date
11/16/2026

Signature 3

Reporting person
Perceptive Life Sciences Master Fund, Ltd.
Signed
/s/ Joseph Edelman
Title
Joseph Edelman, Managing Member
Date
11/16/2026

Signature 4

Reporting person
C2 Life Sciences LLC
Signed
/s/ Joseph Edelman
Title
Joseph Edelman, Managing Member
Date
11/16/2026

Company context

Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company’s proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome’s development of SimpleScreen™ CRC for colorectal cancer screening and a pipeline of tests for lung cancer and additional indications is designed to increase cancer detection among millions of at-risk individuals. For more information, visit www.freenome.com.

Current securities

Historical securities (1)

Recent company filings

  1. SCHEDULE 13G/A - filed by ADAR1 Capital Management, LLC regarding Freenome, Inc.Nov 16, 2026
  2. SCHEDULE 13G/A - filed by Point72 Asset Management, L.P. regarding Freenome, Inc.Nov 16, 2026
  3. SCHEDULE 13G/A - filed by Holocene Advisors, LP regarding Freenome, Inc.Nov 16, 2026
  4. SCHEDULE 13G/A - filed by One Fin Capital Management LP regarding Freenome, Inc.Nov 16, 2026
  5. SCHEDULE 13G/A - filed by RTW INVESTMENTS, LP regarding Freenome, Inc.Nov 16, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.